Dashboard
Manage Tickers

OMCLOMNICELL, INC.

Nasdaq omnicell.com


$ 44.49 $ -0.78 (-1.72 %)    

Friday, 30-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 44.48
$ 44.48 x 100
-- x --
-- - --
$ 25.12 - $ 61.44
281,215
na
2.05B
$ 0.97
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-07-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 11-03-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-05-2023 03-31-2023 10-Q
7 03-01-2023 12-31-2022 10-K
8 11-04-2022 09-30-2022 10-Q
9 08-08-2022 06-30-2022 10-Q
10 05-09-2022 03-31-2022 10-Q
11 02-25-2022 12-31-2021 10-K
12 11-05-2021 09-30-2021 10-Q
13 08-06-2021 06-30-2021 10-Q
14 05-04-2021 03-31-2021 10-Q
15 02-24-2021 12-31-2020 10-K
16 10-30-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-08-2020 03-31-2020 10-Q
19 02-26-2020 12-31-2019 10-K
20 11-01-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-03-2019 03-31-2019 10-Q
23 02-27-2019 12-31-2018 10-K
24 11-02-2018 09-30-2018 10-Q
25 08-03-2018 06-30-2018 10-Q
26 05-04-2018 03-31-2018 10-Q
27 02-27-2018 12-31-2017 10-K
28 11-03-2017 09-30-2017 10-Q
29 08-04-2017 06-30-2017 10-Q
30 05-05-2017 03-31-2017 10-Q
31 02-28-2017 12-31-2016 10-K
32 11-07-2016 09-30-2016 10-Q
33 08-05-2016 06-30-2016 10-Q
34 05-06-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-06-2015 09-30-2015 10-Q
37 08-07-2015 06-30-2015 10-Q
38 05-08-2015 03-31-2015 10-Q
39 03-30-2015 12-31-2014 10-K
40 11-10-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

the-analyst-landscape-5-takes-on-omnicell
The Analyst Landscape: 5 Takes On Omnicell
08/23/2024 14:00:42

jp-morgan-maintains-neutral-on-omnicell-raises-price-target-to-37
JP Morgan Maintains Neutral on Omnicell, R...
08/23/2024 13:26:48

JP Morgan analyst Anne Samuel maintains Omnicell (NASDAQ:OMCL) with a Neutral and raises the price target from $26 to $37.

omnicell-announces-central-med-automation-service-a-subscription-based-solution-designed-to-help-health-systems-establish-and-continuously-optimize-centralized-medication-management-for-cpcs-and-similar-operations
Omnicell Announces Central Med Automation ...
08/20/2024 20:39:49

Full-Service, Scalable Solution Designed to Help Health Systems Establish and Continuously Optimize Centralized Medication Mana...

wells-fargo-maintains-equal-weight-on-omnicell-raises-price-target-to-30
Wells Fargo Maintains Equal-Weight on Omni...
08/02/2024 18:30:41

Wells Fargo analyst Stan Berenshteyn maintains Omnicell (NASDAQ:OMCL) with a Equal-Weight and raises the price target from $...

b-of-a-securities-maintains-buy-on-omnicell-raises-price-target-to-44
B of A Securities Maintains Buy on Omnicel...
08/02/2024 18:26:24

B of A Securities analyst Allen Lutz maintains Omnicell (NASDAQ:OMCL) with a Buy and raises the price target from $34 to $44.

barclays-upgrades-omnicell-to-equal-weight-raises-price-target-to-39
Barclays Upgrades Omnicell to Equal-Weight...
08/02/2024 13:23:30

Barclays analyst Stephanie Davis upgrades Omnicell (NASDAQ:OMCL) from Underweight to Equal-Weight and raises the price targe...

crude-oil-moves-lower-moderna-shares-plunge
Crude Oil Moves Lower; Moderna Shares Plunge
08/01/2024 18:34:37

dow-dips-over-500-points-ism-manufacturing-pmi-falls-in-july
Dow Dips Over 500 Points; ISM Manufacturin...
08/01/2024 16:06:46

air-products-posts-upbeat-earnings-joins-meta-exact-sciences-shake-shack-clearwater-analytics-and-other-big-stocks-moving-higher-on-thursday
Air Products Posts Upbeat Earnings, Joins ...
08/01/2024 15:42:35

omnicell-sees-fy24-revenues-between-107b-1110b-vs-106b-estimate-prior-view-1045b-1120b-with-adjusted-eps-of-120-150-vs-111-estimate-prior-view-090---140
Omnicell Sees FY24 Revenues Between $1.07B...
08/01/2024 11:17:41

Based on strong first half performance and current visibility of the business, the Company is updating the previously provided ...

omnicell-q2-adj-051-beats-014-estimate-sales-27679m-beat-25520m-estimate
Omnicell Q2 Adj $0.51 Beats $0.14 Estimate...
08/01/2024 11:12:52

Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.14 by 264...

benchmark-reiterates-buy-on-omnicell-maintains-38-price-target
Benchmark Reiterates Buy on Omnicell, Main...
07/15/2024 12:47:34

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:OMCL) with a Buy and maintains $38 price target.

benchmark-reiterates-buy-on-omnicell-maintains-38-price-target
Benchmark Reiterates Buy on Omnicell, Main...
05/03/2024 17:17:50

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:OMCL) with a Buy and maintains $38 price target.

omnicell-reaffirms-fy24-outlook-adj-eps-090-140-vs-107-est-sees-sales-1045b-1120b-vs-106b-est
Omnicell Reaffirms FY24 Outlook: Adj EPS $...
05/02/2024 11:47:47

The table below summarizes Omnicell's second quarter and full year 2024 guidance outlined above.   ...

omnicell-q2-outlook-total-revenues-250m---260m-vs-26188m-estimate-adj-eps-010-020-vs-027-estimate
Omnicell Q2 Outlook: Total Revenues $250M ...
05/02/2024 11:42:09

The table below summarizes Omnicell's second quarter and full year 2024 guidance outlined above.   ...

omnicell-q1-2024-adj-eps-003-beats-009-estimate-sales-246150m-beat-236754m-estimate
Omnicell Q1 2024 Adj EPS $0.03 Beats $(0.0...
05/02/2024 11:37:08

Omnicell (NASDAQ:OMCL) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.09) by 1...

benchmark-reiterates-buy-on-omnicell-maintains-38-price-target
Benchmark Reiterates Buy on Omnicell, Main...
04/30/2024 14:02:27

Benchmark analyst Bill Sutherland reiterates Omnicell (NASDAQ:OMCL) with a Buy and maintains $38 price target.

Core News & Articles
Clover Health Appoints Peter Kuipers As Ch...
04/22/2024 20:14:47

Clover Health Investments, Corp. (NASDAQ:CLOV) ("Clover," "Clover Health" or the "Company"), a physicia...

omnicell-announces-xt-amplify-a-multi-year-innovation-program-that-is-intended-to-maximize-value-for-hospitals-health-systems-and-post-acute-care-facilities-that-have-invested-in-omnicells-xt-automated-dispensing-system
Omnicell Announces XT Amplify, A Multi-Yea...
04/16/2024 20:14:53

Multi-year Innovation Program Designed to Maximize Value and Outcomes for XT Automated Dispensing SystemOmnicell, Inc. (NASDAQ:...

benchmark-maintains-buy-on-omnicell-lowers-price-target-to-38
Benchmark Maintains Buy on Omnicell, Lower...
02/09/2024 19:34:36

Benchmark analyst Bill Sutherland maintains Omnicell (NASDAQ:OMCL) with a Buy and lowers the price target from $42 to $38.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION